3rd Quarter - Report

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Prospective legislation known as 21st Century Cures 2.0 -Cannabis Administration and Opportunity Act (CAOA) Discussion Draft -National paid family and medical leave -Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act (H.R.3354)

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 3354 (117th)

Medicare/Medicaid MMM

Held meetings and submitted letters on prescription drug pricing reform recommendations including measures to enhance affordability, limiting out-of-pocket expenses for beneficiaries, moderating annual increases in drug prices, restructuring the cost-sharing, expanding Medicare services to include dental, hearing, and vision, and recommended a federal ban on the quality-adjusted life year. Submitted comments on CMS Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease CAG-00460N Submitted letter CMS-1746-P: Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2022 Signed letter on priorities for Telehealth Reform Signed letter on the Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals Signed letter on the BIOSIM Act (H.R 2815) Signed letter on Request for Information (RFI): Methods and Leading Practices for Advancing Equity and Support for Underserved Communities Through Government Submitted comments on the CY 2022 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS-1753-P) Submitted comments on the Revisions to Payment Policies under the Medicare Physician Fee Schedule Quality Payment Program and Other Revisions to Part B for CY 2022 (CMS-1751-P)

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: White House Office; SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2815 (117th)

Medical/Disease Research/Clinical Labs MED

-Establishing a Neuroscience Center of Excellence within the FDA

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern. Rep. Ed Perlmutter
MICHAEL WARD —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.